Buscar
Mostrando ítems 1-10 de 13
Analysis of variants in the HCN4 gene and in three single nucleotide polymorphisms of the CYP3A4 gene for association with ivabradine reduction in heart rate: a preliminary report
(Via Médica, 2016)
[Abstract] Background: Ivabradine, a selective bradycardic drug, inhibits the If. In patients with heart failure (HF), ivabradine reduces the risk of rehospitalization and mortality. The average heart rate (HR) reduction ...
Valor pronóstico de un nuevo modelo de evaluación clínica de pacientes ambulatorios con insuficiencia cardiaca
(Elsevier, 2021-06-04)
[Resumen] Introducción y objetivos. Estudiar el valor pronóstico de un modelo de 5 ítems clínicos basado en las recomendaciones IC-BERG para la evaluación en consulta de pacientes ambulatorios con insuficiencia cardiaca ...
Advanced heart failure: a position statement of the Heart Failure Association of the European Society of Cardiology
(Wiley, 2018-05-27)
[Abstract] This article updates the Heart Failure Association of the European Society of Cardiology (ESC) 2007 classification of advanced heart failure and describes new diagnostic and treatment options for these patients. ...
Light Chain and Transthyretin Cardiac Amyloidosis: Clinical Characteristics, Natural History and Prognostic Factors
(Elsevier, 2021-03-13)
[Abstract]
Introduction and objectives.
Light-chain amyloidosis (AL-CA) and transthyretin amyloidosis (ATTR-CA) are the most common types of cardiac amyloidosis (CA). We sought to study the clinical characteristics and ...
Clinical Profile and Causes of Death According to Ejection Fraction in Patients With Heart Failure Cared for in a Specialized Cardiology Unit
(Elsevier, 2021-05-14)
[Abstract]
Background and objective.
Patients with heart failure are classified into three phenotypes based on left ventricular ejection fraction. This work aimed to compare the clinical profile, treatment, prognosis, ...
Real World Comparison of Spironolactone and Eplerenone in Patients With Heart Failure
(Elsevier, 2022-01-06)
[Abstract] Aims. In the absence of previous direct comparative studies, we aimed to evaluate the effectiveness of spironolactone and eplerenone in patients with heart failure and reduced ejection fraction (HFrEF) in a ...
Comparison of predicted and observed mortality in patients with heart failure treated at a specialized unit
(Elsevier, 2020-01-21)
[Abstract] Introduction and objectives: To analyze survival in heart failure (HF) patients treated at a specialized unit.
Methods: Prospective cohort-based study of HF patients treated at a specialized unit from 2011 ...
Hyperkalemia in Heart Failure Patients in Spain and Its Impact on Guidelines and Recommendations: ESC-EORP-HFA Heart Failure Long-Term Registry
(Elsevier, 2020-04)
[Abstract] Introduction and objectives: Hyperkalemia is a growing concern in the treatment of patients with heart failure and reduced ejection fraction because it limits the use of effective drugs. We report estimates of ...
Furosemida subcutánea mediante infusor elastomérico en pacientes ambulatorios con insuficiencia cardiaca: experiencia inicial
(Asociación Española de Enfermería en Cardiología (AEEC), 2024-02-06)
[Resumen] Introducción. Una causa frecuente de hospitalización en pacientes con insuficiencia cardiaca es congestión refractaria a diuréticos orales y se trata con furosemida intravenosa. La administración de furosemida ...